Estimates Revisions Lisata Therapeutics, Inc.
Stocks
LSTA
US1280583022
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.595 USD | +2.71% |
|
+9.94% | +93.28% |
| 05-29 | Lisata Therapeutics - amends merger offer price to $4 per share plus CVR | RE |
| 05-15 | HC Wainwright Downgrades Lisata Therapeutics to Neutral From Buy | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | - | |||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Stocks
- LSTA Stock
- Consensus Lisata Therapeutics, Inc.
- Estimates Revisions
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
